by Yale University Credit: Pixabay/CC0 Public Domain Yale scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related antibody that can slip, undetected, into “cold” tumors and flip on an immune response that has been turned off by cancer. The research, published in Science Signaling on March 25, offers new findings that could help...
Tag: <span>Cancer Treatment</span>
Post
AI-driven genetic analysis uncovers insights for personalized cancer treatment
by Caitlin Dawson, University of Southern California Gene-treatment interaction analysis across cancer types. Credit: Nature Communications (2024). DOI: 10.1038/s41467-024-55251-5 A study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes—insights that could help doctors tailor treatments more effectively. In the largest study of its kind, the researchers...
Post
Palliative care offers additional help during cancer treatment
by Katrina Nickels, University of Kentucky Credit: Unsplash/CC0 Public Domain When facing a cancer diagnosis, patients often hear the term “palliative care” but may not fully understand what it means. Palliative care is all about improving quality of life and providing patients with an extra layer of support throughout treatment. Think of it as having an...
Post
Immunosuppression study helps understand why some prostate cancer treatments do not work as expected
by Tampere University On the left is a tissue sample from the prostate stained with hematoxylin and eosin. Hematoxylin stains the nuclei blue or purple because it binds to DNA, and eosin stains the cytoplasm and proteins red or pink. This method is used in the diagnosis of prostate cancer. Visium technology (in the centre) allows...
Post
Newfound mechanism may explain why some cancer treatments boost risk of heart disease
Peer-Reviewed Publication NYU Langone Health / NYU Grossman School of Medicine A cancer therapy that prompts the body’s immune defenses against viruses and bacteria to attack tumors can make patients more vulnerable to heart attack and stroke. A possible explanation for this side effect is that the treatment interferes with immune regulation in the heart’s...
Post
New protein discovery may influence future cancer treatment
JULY 25, 2024 by University of Otago Model of the oxidation-induced amyloid formation and disassembly mechanism of p16. Credit: Nature Communications (2024). DOI: 10.1038/s41467-024-49581-7Researchers from the University of Otago, Christchurch, have spearheaded the discovery of a protein function which has the potential to guide the development of novel cancer treatment options and improve the diagnosis...
Post
Scientists use organoid model to identify potential new pancreatic cancer treatment
by Weill Cornell Medical College Perhexiline maleate induces cell death of human pancreatic cancer organoids. (Red: Cell death marker; Blue: DAPI). Credit: Xiaohua DuanA drug screening system that models cancers using lab-grown tissues called organoids has helped uncover a promising target for future pancreatic cancer treatments, according to a new study from researchers at Weill Cornell...
Post
YouTube will remove cancer treatment misinformation
PUBLISHED TUE, AUG 15 2023 9:37 AM EDT YouTube on Tuesday announced a new policy for combatting medical misinformation on the video-sharing platform. The company will remove content that contradicts well-established guidance from health officials about topics like Covid-19, reproductive health, cancer and harmful substances, among others. YouTube said it will determine whether a condition...
Post
Previously unknown material could revolutionize cancer treatment
Tiny “dots” transform light, enabling big advancements UNIVERSITY OF CALIFORNIA – RIVERSIDE IMAGE: NEW MATERIAL COULD IMPRO A new material, created at the little-explored intersection of organic and inorganic chemistry, could not only enable more powerful solar panels, but it could also usher in the next generation of cancer treatments. Described in a Nature Chemistry journal paper published today,...
Post
Bioengineering active immunotherapy for personalized cancer treatment
by Thamarasee Jeewandara, Medical Xpress Design of IL2-ep13nsEV and its utilization in treating breast cancer. To generate this active immunotherapy, the sEVs from autologous DCs are engineered with surface membrane–bound IL2 by expressing IL2-MFG-E8. This personalization of DC-derived sEV (p13nsEV) is achieved by loading lysed surgically harvested breast cancer cells onto engineered autologous DCs followed...